More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Launches New Natural Orange-Flavored CBD Tincture

Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Launches New Natural Orange-Flavored CBD Tincture

by adminAdrianRamirez | May 15, 2019 | Dixie Botanicals, Press Releases

SAN DIEGO, May 15, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary Dixie Botanicals® has released a new orange-flavored cannabidiol (CBD) Isolate Tincture. Each 1 oz....
Medical Marijuana, Inc. Major Investment Company Axim® Biotechnologies Files New U.S. Provisional Patent for Cannabis Gum as a Treatment for Migraine Symptoms

Medical Marijuana, Inc. Major Investment Company Axim® Biotechnologies Files New U.S. Provisional Patent for Cannabis Gum as a Treatment for Migraine Symptoms

by adminAdrianRamirez | May 14, 2019 | Axim Biotechnologies, Press Releases

NEW YORK, May 14, 2019 — Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company’s major investment company AXIM® Biotechnologies, Inc. (AXIM) (“AXIM”), a world...
Direct Selling News, Yahoo Finance, Grizzle, and Rogue Magazine Feature Coverage of Medical Marijuana, Inc. Companies This Week

Direct Selling News, Yahoo Finance, Grizzle, and Rogue Magazine Feature Coverage of Medical Marijuana, Inc. Companies This Week

by adminAdrianRamirez | May 9, 2019 | Media Coverage

CBD education for doctors, CBD cat treats, and becoming a top 100 global company lead Medical Marijuana, Inc. headlines this week. As CBD continues to trend as a topic among major media outlets, the Medical Marijuana, Inc. portfolio of companies received coverage from...
Direct Selling News, Yahoo Finance, Grizzle, and Rogue Magazine Feature Coverage of Medical Marijuana, Inc. Companies This Week

DIRECT SELLING NEWS, YAHOO FINANCE, GRIZZLE, UND ROGUE MAGAZINE BERICHTEN ÜBER MEDICAL MARIJUANA, INC. – UNTERNEHMEN DER WOCHE

by adminAdrianRamirez | May 9, 2019 | Media Coverage

MEDICAL MARIJUANA, INC. – DIE SCHLAGZEILEN DIESER WOCHE SIND: CBD SCHULUNG FÜR ÄRZTE, CBD-KATZENNAHRUNG UND ZU EINEM DER 100 WELTWEIT FÜHRENDEN UNTERNEHMEN DER WELT WERDEN Da das Thema CBD in den wichtigsten Medien weiterhin im Trend liegt, wurde über das...
Medical Marijuana, Inc. Announces April 2019 as the Largest Sales Bookings Month in Company History

Medical Marijuana, Inc. Announces April 2019 as the Largest Sales Bookings Month in Company History

by adminAdrianRamirez | May 9, 2019 | Press Releases

SAN DIEGO, May 9, 2019 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the company had its the largest-ever (unaudited) sales bookings month in its history in April 2019. The...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.